(EMUAA) UBS(Lux)Fund Solutions – - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: EUR • Type: Etf • ISIN: LU0950668870 • Eurozone Large-Cap Equity
EMUAA: ETF, Eurozone, Equities, Large-Cap, UCITS
The UBS (Lux) Fund Solutions – MSCI EMU UCITS ETF (EUR) A-acc (SW: EMUAA) is designed to provide investors with exposure to the performance of large-cap equities within the Eurozone. The fund tracks the MSCI EMU Index (Net Return), which includes companies from countries in the European Monetary Union (EMU). Additionally, currency-hedged share classes are available to mitigate the impact of currency fluctuations between the investors reference currency and the Euro. This is achieved through the use of currency forward contracts, which are aligned with the hedging methodology of the indexs currency-hedged variant.
The ETF is structured as a UCITS-compliant fund, offering a cost-efficient way to gain exposure to the Eurozone equity market. It is listed on the Swiss exchange (SW) under the ticker symbol EMUAA and is classified under the Eurozone Large-Cap Equity category. The funds technical profile includes an average 20-day trading volume of 58,282 shares, with a last price of 32.63. Key technical indicators such as the 20, 50, and 200-day simple moving averages (SMA) stand at 31.61, 32.95, and 31.21, respectively. The Average True Range (ATR) of 0.69 indicates relatively stable price movements. From a fundamental perspective, the fund manages assets under management (AUM) of 2,572.64 million EUR, underscoring its liquidity and investor confidence.
For the next three months, the ETFs performance is expected to align closely with the broader Eurozone equity market trends. Based on technical analysis, the funds price is currently trading above its 20-day and 50-day SMAs but below its 200-day SMA, suggesting a potential trend reversal if it breaks above the 200-day SMA. The ATR of 0.69 indicates moderate volatility, which is likely to persist. From a fundamental standpoint, the Eurozones economic recovery, coupled with monetary policy support, could drive positive sentiment toward large-cap equities, potentially benefiting the fund. However, external risks such as geopolitical tensions or economic downturns may weigh on performance. The funds significant AUM and liquidity position it as a stable investment vehicle for exposure to the Eurozone market.
Additional Sources for EMUAA ETF
EMUAA ETF Overview
Market Cap in USD | 2,913m |
Category | Eurozone Large-Cap Equity |
TER | 0.10% |
IPO / Inception | 2016-08-12 |
EMUAA ETF Ratings
Growth Rating | 71.0 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -0.47 |
Analysts | - |
Fair Price Momentum | 32.60 EUR |
Fair Price DCF | - |
EMUAA Dividends
No Dividends PaidEMUAA Growth Ratios
Growth Correlation 3m | -42.4% |
Growth Correlation 12m | 48.3% |
Growth Correlation 5y | 86.9% |
CAGR 5y | 14.34% |
CAGR/Max DD 5y | 0.58 |
Sharpe Ratio 12m | 2.43 |
Alpha | -0.70 |
Beta | 0.569 |
Volatility | 19.64% |
Current Volume | 69.8k |
Average Volume 20d | 74.7k |
As of May 02, 2025, the stock is trading at EUR 32.95 with a total of 69,815 shares traded.
Over the past week, the price has changed by +1.82%, over one month by -0.77%, over three months by +1.95% and over the past year by +9.93%.
Yes. Based on ValueRay Analyses, UBS(Lux)Fund Solutions – (SW:EMUAA) is currently (May 2025) a good stock to buy. It has a ValueRay Growth Rating of 70.97 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EMUAA as of May 2025 is 32.60. This means that EMUAA is currently overvalued and has a potential downside of -1.06%.
UBS(Lux)Fund Solutions – has no consensus analysts rating.
According to ValueRays Forecast Model, EMUAA UBS(Lux)Fund Solutions – will be worth about 36.6 in May 2026. The stock is currently trading at 32.95. This means that the stock has a potential upside of +10.93%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 36.6 | 10.9% |